Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Genomics Personalized Health Market Forecast: What Value Will The Market Reach By 2030?
The market size for genomics personalized health has seen substantial growth recently. It is set to expand from $18.5 billion in 2025 to $21.46 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.0%. This historical increase is largely due to advances in sequencing technologies, decreasing costs of genomic testing, the expansion of clinical genomics research, a rise in personalized medicine initiatives, and greater availability of bioinformatics tools.
The genomics personalized health market size is projected to experience swift expansion over the coming years. Its value is anticipated to reach $36.55 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 14.2%. This projected growth during the forecast timeframe stems from factors such as the greater uptake of population-level genomics initiatives, increased capital allocation towards AI-powered diagnostics, the broadening scope of personalized treatments, the deeper incorporation of genomics into standard clinical practices, and a heightened emphasis on healthcare models focused on prediction. Key developments expected in this period encompass the wider deployment of genomic data analysis platforms, the escalating application of artificial intelligence for interpreting genetic variants, the widening availability of tailored treatment approaches, the deeper embedding of genomics within preventive health strategies, and an intensified concentration on diagnostic precision.
Get A Free Sample Report With In-Depth Market Insights:
Genomics Personalized Health Market Industry Drivers: What’s Behind The Revenue Growth?
The increasing requirement for personalized medicine is set to boost the expansion of the genomics personalized health market. Personalized medicine, also known as precision medicine, is a healthcare methodology that customizes medical interventions and practices to fit each patient’s unique characteristics. This heightened demand for personalized medicine is attributed to a transition towards preventive healthcare, enhanced treatment results, greater patient empowerment and engagement, economic advantages, and a rising prevalence of chronic and complex conditions. Genomics personalized health significantly advances personalized medicine by utilizing individual genetic information to tailor medical care, spanning from prevention and diagnosis to treatment and monitoring. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the Food and Drug Administration (FDA) approved 16 novel personalized therapies for patients with rare diseases in 2023, up from six in 2022. Consequently, the growing need for personalized medicine is a primary driver for the genomics personalized health market.
Genomics Personalized Health Market Breakdown By Product Type And Application
The genomics personalized health market covered in this report is segmented –
1) By Test Type: Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing
2) By Technology: NGS Platforms, Microarray, Genetic Analyzers
3) By End User: Academic Research Institutes, Diagnostic Centers, Other End Users
Subsegments:
1) By Oncology Testing: Cancer Genomic Profiling, Liquid Biopsy Testing, Tumor Mutational Burden Testing, Genetic Biomarker Testing
2) By Infectious Disease Testing: Next-Generation Sequencing (NGS) Tests, Microbial Genomic Profiling
3) By Orphan Disease Testing: Genetic Screening For Rare Diseases, Genetic Testing For Inherited Disorders, Targeted Gene Panels
4) By Autoimmune Disease Testing: Genetic Screening For Autoimmune Conditions, Immune System Gene Profiling, HLA Typing Tests
5) By Obstetrics Testing: Non-Invasive Prenatal Testing (NIPT), Genetic Screening For Birth Defects, Carrier Screening Tests
#Genomics Personalized Health Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies in the genomics personalized health market are concentrating on developing innovative products, such as cloud-based software tailored for tertiary analysis of clinical next-generation sequencing (NGS) data, to gain a competitive edge. Clinical next-generation sequencing (NGS) data represents genetic information produced by sequencing technologies, allowing for thorough, high-throughput analysis of DNA or RNA samples within a clinical context. For instance, in March 2023, Illumina, a US-based biotechnology company specializing in DNA sequencing and array-based technologies, introduced Connected Insights, a cloud-based software engineered for the tertiary analysis of clinical next-generation sequencing (NGS) data. This platform aims to optimize the interpretation and reporting processes, particularly for oncology applications, and supports extensive genomic profiling. Connected Insights integrates various third-party knowledge bases, thereby facilitating precise data analysis and improving the efficiency of precision care initiatives.
Genomics Personalized Health Market Company Landscape And Competitive Strategy
Major companies operating in the genomics personalized health market are Illumina Inc., Quest Diagnostics, Exact Sciences Corporation, Natera Inc., Adaptive Biotechnologies Corporation, Myriad Genetics Inc., Pacific Biosciences of California Inc., Personalis Inc., Invitae Corporation, GRAIL Inc., XCode Life Sciences Private Limited, BGI Genomics Co. Ltd., Genetic Technologies Limited, Eastern Biotech and Life Sciences, Tempus AI, Guardant Health, Freenome, Color Genomics, Helix, NantOmics, Novogenia GmbH, Clear Labs
View The Full Genomics Personalized Health Market Report:
Genomics Personalized Health Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the personalized health market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics personalized health market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
